13F HOLDINGS REPORT
Rosalind Advisors, Inc.
Quarter ended Q4 2025 · Filed February 12, 2026 · Accession 0001622627-26-000011
Total Value
$284.5M
Positions
42
Other Managers
0
Confidential Omitted
No
Holdings (42)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | DELCATH SYSTEMS, INC. | DCTH | 3,300,389 | $33.0M | 11.60% |
| 2 | SAVARA INC | SVRA | 3,403,721 | $20.5M | 7.21% |
| 3 | FENNEC PHARMACEUTICALS INC | FENC | 2,613,508 | $20.1M | 7.07% |
| 4 | XERIS BIOPHARMA HOLDGS INC | XERS | 2,111,700 | $16.6M | 5.83% |
| 5 | VIRIDIAN THERAPEUTICS INC | VRDN | 450,000 | $14.0M | 4.92% |
| 6 | MEDIWOUND LTD | MDWD | 749,054 | $13.8M | 4.86% |
| 7 | VERASTEM INC | VSTM | 1,788,475 | $13.8M | 4.85% |
| 8 | REPLIMUNE GROUP INC | REPL | 1,410,497 | $13.7M | 4.82% |
| 9 | ASTRIA THERAPEUTICS INC | ATYR | 1,039,080 | $13.6M | 4.78% |
| 10 | CYBIN INC | HELP | 1,657,540 | $13.6M | 4.77% |
| 11 | EYEPOINT PHARMACEUTICALS INC | EYPT | 690,000 | $12.6M | 4.43% |
| 12 | CG ONCOLOGY INC | CGON | 300,000 | $12.5M | 4.38% |
| 13 | CYTOKINETICS INC | CYTK | 195,045 | $12.4M | 4.36% |
| 14 | X4 PHARMACEUTICALS INC | XFOR | 2,605,920 | $10.4M | 3.66% |
| 15 | MIND MEDICINE MINDMED INC | 60255C885 | 750,000 | $10.0M | 3.53% |
| 16 | PROFOUND MEDICAL CORP | PROF | 1,068,955 | $8.4M | 2.96% |
| 17 | INSPIREMD INC | NSPR | 3,905,743 | $7.0M | 2.44% |
| 18 | Ocular Therapeutix, Inc | OCUL | 400,000 | $4.9M | 1.71% |
| 19 | ARRIVENT BIOPHARMA INC | AVBP | 215,871 | $4.3M | 1.53% |
| 20 | TALPHERA INC | TLPH | 3,579,273 | $4.1M | 1.43% |
| 21 | MYOMO INC | MYO | 3,839,772 | $3.5M | 1.23% |
| 22 | INVESCO QQQ TR | IVZ | 450,000 | $3.0M | 1.06% |
| 23 | POLYPID LTD | PYPD | 696,556 | $3.0M | 1.06% |
| 24 | ONKURE THERAPEUTICS INC | OKUR | 730,488 | $2.1M | 0.74% |
| 25 | SPDR S&P 500 ETF TR | SPY | 510,000 | $1.9M | 0.66% |
| 26 | ANAVEX LIFE SCIENCES CORP | AVXL | 1,168,600 | $1.9M | 0.66% |
| 27 | REGENTIS BIOMATERIALS LTD | RGNT | 251,510 | $1.7M | 0.60% |
| 28 | SPDR SERIES TRUST | 78464A950 | 1,937,600 | $1.3M | 0.47% |
| 29 | TREVI THERAPEUTICS INC | TRVI | 100,000 | $1.3M | 0.44% |
| 30 | ISHARES TR | 464287955 | 200,000 | $1.1M | 0.39% |
| 31 | NEURAXIS INC | NRXS | 286,138 | $1.0M | 0.37% |
| 32 | KURA ONCOLOGY INC | KURA | 100,000 | $1.0M | 0.37% |
| 33 | FRACTYL HEALTH INC | GUTS | 385,731 | $848,608 | 0.30% |
| 34 | BIOFRONTERA INC | BFRIW | 1,140,764 | $650,235 | 0.23% |
| 35 | ARRIVENT BIOPHARMA INC | AVBP | 107,900 | $539,500 | 0.19% |
| 36 | VERASTEM INC | VSTM | 268,600 | $159,810 | 0.06% |
| 37 | UNIQURE NV | QURE | 100,000 | $95,000 | 0.03% |
| 38 | REPLIMUNE GROUP INC | REPL | 230,900 | $11,545 | 0.00% |
| 39 | VIKING THERAPEUTICS INC | VKTX | 100,000 | $2,000 | 0.00% |
| 40 | VISTAGEN THERAPEUTICS INC | VTGN | 493,400 | $0 | 0.00% |
| 41 | REPLIMUNE GROUP INC | REPL | 264,700 | $0 | 0.00% |
| 42 | REZOLUTE INC | RZLT | 263,100 | $0 | 0.00% |